AliveCor Demos Concept for 12-Lead Mobile ECG

Fed up with criticism that the AliveCor ECG isn't as good as a traditional 12-lead ECG used in hospitals AliveCor co-founder Dr. Dave Albert took to the stage at USC's 7th annual Body Computing Conference to dispel myths and announce new developments at the company.

A recently completed studyby USC medical students found that the AliveCor is just as accurate as a 12-lead ECG in detecting a number of conditions including atrial fibrillation.

AliveCor co-founder Dr. Dave Albert demos a concept of a 12-lead mobile ECG. 

(image via Twitter user @WilliamVanNoll)

Acknowledging that data alone isn't sufficient for many, Albert also demonstrated a concept of a 12-lead version of the AliveCor heart monitor to the audience in attendance. While more cumbersome than the simple 1-lead AliveCor that attaches to your smartphone (which the company acknowledges is not intended to replace a 12-lead ECG machine), the 12-lead concept did offer time- and space-saving opportunities and was just as accurate as a traditional machine in getting readings from a student volunteer.
The concept devices consists of a wrist attachment and a lead device, both of which connect to a smartphone. Rather than attaching 12 individual leads to the body, a clinician can obtain readings by pressing the single lead to each individual point of contact. Obviously, this requires clinical training and knowledge of where to obtain proper readings, but Albert proposed the 12-lead AliveCor as an excellent means for obtaining readings in remote or mobile locations or when space and time restrictions do not allow for a traditional 12-lead ECG machine. The device would also allow for sharing and storage on the cloud.
Earlier that day AliveCor also announced a new version of its heart monitor that is compatible with Android devices. The new versatile heart monitor is FDA-cleared and features a universal attachment plate allowing it connect to Apple iPhones as well as Android phones including the Samsung Galaxy S3, S4, and HTC One. The new version will also allow patients to share their data via Instagram. The company is also currently working in collaboration with the USC Center for Body Computing on a year-long study to collect and review data from the AliveCor heart monitor.
AliveCor co-founder Dave Albert will be speaking at The Wireless Medical Devices West conference on The Impact of the Quantified Self Movement on Healthcare on Dec 3rd, 2013 as par of Biomedevice San Jose.
-Chris Wiltz, Associate Editor, MD+DI
[email protected]
Filed Under
500 characters remaining